SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Vallon Pharmaceuticals, Inc. VLON NASDAQ

NASDAQ Capital Marke • Healthcare • Biotechnology • US • USD

SharesGrow Intrinsic Value

Negative cash flow

Vallon Pharmaceuticals, Inc. (VLON) has 12 identified peers for comparison in the Healthcare sector. Peers include ALLR, ATNF, CDIO, CFRX, CLNN, CNSP and others.

Peers & Similar Companies — VLON

Allarity Therapeutics, Inc.

$1.19 -0.76% $18.82M

180 Life Sciences Corp.

$7.04 -7.49% $1.08B

Cardio Diagnostics Holdings, Inc.

$1.92 +2.13% $3.56M

ContraFect Corporation

$6.68 +3.01% $66.75M

CNS Pharmaceuticals, Inc.

$2.64 +5.18% $1.52M

Foghorn Therapeutics Inc.

$4.85 +3.41% $284.7M

Werewolf Therapeutics, Inc.

$0.92 -0.01% $44.59M

Ikena Oncology, Inc.

$17.16 +1,152.55% $718.82M

$22.90 +1.24% $2.01B

Palisade Bio, Inc.

$2.06 +3.52% $341.72M

Panbela Therapeutics, Inc.

$0.00 -96.08% $971.00

People Also View

180 Life Sciences Corp.

Ikena Oncology, Inc.

Zura Bio Limited

Palisade Bio, Inc.

Foghorn Therapeutics Inc.

Unicycive Therapeutics, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message